Last quarter (Q4 2022), ADC Therapeutics's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q4, ADC Therapeutics's net income was $―. See ADC Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 140.11M	$ 209.91M	$ 33.92M	$ 0.00	$ 2.34M	$ 1.14M
Cost of Revenue	$ 4.09M	$ 4.58M	$ 1.39M	$ 0.00	-	-
Gross Profit	$ 136.02M	$ 205.33M	$ 32.52M	$ 0.00	-	-
Operating Expense	$ 248.91M	$ 328.96M	$ 312.58M	$ 219.26M	$ 121.74M	$ 127.08M
Operating Income	$ -112.89M	$ -123.63M	$ -280.06M	$ -219.26M	$ -119.40M	$ -125.94M
Net Non Operating Interest Income Expense	$ -10.78M	$ -18.95M	$ 66.00K	$ -4.09M	$ 2.10M	$ 2.86M
Other Income Expense	$ -10.80M	$ 167.88M	$ 201.54M	$ -22.61M	$ 1.40M	$ 213.00K
Pretax Income	$ -134.47M	$ -310.46M	$ -481.53M	$ -245.96M	$ -115.90M	$ -122.87M
Tax Provision	$ -2.83M	$ 1.14M	$ -21.48M	$ 327.00K	$ 582.00K	$ 224.00K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -131.64M	$ -311.60M	$ -460.05M	$ -246.29M	$ -116.48M	$ -123.10M
Basic EPS	$ -1.71	$ -1.99	$ -3.00	$ -3.77	$ -2.16	$ -2.29
Diluted EPS	$ -1.71	$ -1.99	$ -3.00	$ -3.77	$ -2.16	$ -2.29
Basic Average Shares	$ 232.11M	$ 78.15M	$ 76.75M	$ 65.41M	$ 53.83M	$ 53.83M
Diluted Average Shares	$ 232.11M	$ 78.15M	$ 76.75M	$ 65.41M	$ 53.83M	$ 53.83M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	$ -0.96	-	-	$ -2.69	-	-
Reported Normalized Diluted E P S	$ -0.96	-	-	$ -2.69	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 253.00M	$ 333.54M	$ 313.98M	$ 219.26M	$ 121.74M	$ 127.08M
Net Income From Continuing And Discontinued Operation	$ -131.64M	$ -311.60M	$ -460.05M	$ -246.29M	$ -116.48M	$ -123.10M
Normalized Income	$ -114.82M	-	-	$ -205.79M	$ -116.27M	$ -123.27M
Interest Expense	$ 29.37M	-	-	$ 4.93M	$ 156.00K	$ 0.00
EBIT	$ -105.10M	$ -273.54M	$ -481.53M	$ -241.04M	$ -115.75M	$ -122.87M
EBITDA	$ -103.34M	$ -273.42M	$ -481.40M	$ -238.85M	$ -114.10M	$ -122.13M

Currency in USD

ADC Therapeutics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing